European Business to Increase R&D Spending Despite Crisis

Top EU businesses expect their investments in research and development to grow by an average of 4% annually over the period 2012 to 2014, according to a Commission survey of some of Europe's companies that invest the most in R&D. The figures show the importance that these companies place on R&D as a key factor for their future growth and prosperity, despite the current economic difficulties. The front runner is the software and computer services sector, which expects R&D investment to grow by 11% per year on average. In-house R&D is seen as the most relevant driver of innovation by the surveyed companies, followed by market research and related activities for new product introduction.

"This positive trend for corporate R&D investment is essential for European competitiveness," said Máire Geoghegan-Quinn, Commissioner for Research, Innovation and Science. "These companies are the main drivers in making the European economy more knowledge-based and smarter. Our future research and innovation programme, Horizon 2020, will give a further boost to innovative enterprises."

When asked about effects of policies and external factors on their innovation activities, surveyed companies highlighted the strong positive effects of fiscal incentives, national grants, EU financial support and public-private partnerships both at national and EU level. In contrast, the time needed to obtain intellectual property right protection and the costs of that protection were seen by many companies as key factors impacting negatively on their innovation activities. This confirms the importance of an efficient IPR regime for fostering companies’ innovation activities.

The surveyed companies were also asked about the importance of various ways to share knowledge. Collaboration agreements with other companies stand out as the most important. For companies active in high R&D intensity sectors, this is followed by licensing in/out with other companies, and then agreements with higher education institutions and other public research organisations. For companies in medium and low R&D intensity sectors, collaboration agreements with higher education institutions and other public research organisations are seen as more important than licensing. In general, the results show the strong importance given to these various ways of sharing knowledge by many companies, which could be a sign of the increasing role of open innovation.

The EU Survey on R&D Investment Business Trends was carried out by the European Commission's Joint Research Centre (JRC) at the Institute for Prospective Technological Studies (IPTS) and the Directorate General for Research and Innovation.

The survey results are based on 187 responses of mainly larger companies from the 1,000 EU-based companies in the 2011 EU Industrial R&D Investment Scoreboard (IP/11/1205 and MEMO/11/705). These responses were collected between 16 January and 28 April 2012.

Taken together, these 187 companies are responsible for R&D investment worth almost €45 billion, constituting around 40% of the total R&D investment by the 1,000 EU Scoreboard companies, which is a significant share of European business investment in R&D. The 4% average growth level is slightly down on the 5% growth expected in the previous survey, reflecting the worsening of the economic context.

By end-2012 the European Commission will publish its next EU Industrial R&D Investment Scoreboard, which ranks the worldwide biggest companies investing in R&D.

For further information and the survey is available at:
http://iri.jrc.es/reports.htm

Most Popular Now

Accelerating NHS Digital Maturity: Paper…

Digitised clinical noting at South Tees Hospitals NHS Foundation Trust is creating efficiencies for busy doctors and nurses. The trust’s CCIO Dr Andrew Adair, deputy CCIO Dr John Greenaway, and...

AI Tool Helps Predict Who will Benefit f…

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who...

New Study Shows Promise for Gamified mHe…

A new study published in Multiple Sclerosis and Related Disorders highlights the potential of More Stamina, a gamified mobile health (mHealth) app designed to help people with Multiple Sclerosis (MS)...

AI in Healthcare: How do We Get from Hyp…

The Highland Marketing advisory board met to consider the government's enthusiasm for AI. To date, healthcare has mostly experimented with decision support tools, and their impact on the NHS and...

Research Shows AI Technology Improves Pa…

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

New AI Tool Accelerates Disease Treatmen…

University of Virginia School of Medicine scientists have created a computational tool to accelerate the development of new disease treatments. The tool goes beyond current artificial intelligence (AI) approaches by...

DMEA sparks: The Future of Digital Healt…

8 - 10 April 2025, Berlin, Germany. Digitalization is considered one of the key strategies for addressing the shortage of skilled workers - but the digital health sector also needs qualified...

First Therapy Chatbot Trial Shows AI can…

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results...

Who's to Blame When AI Makes a Medi…

Assistive artificial intelligence technologies hold significant promise for transforming health care by aiding physicians in diagnosing, managing, and treating patients. However, the current trend of assistive AI implementation could actually...

DeepSeek: The "Watson" to Doct…

DeepSeek is an artificial intelligence (AI) platform built on deep learning and natural language processing (NLP) technologies. Its core products include the DeepSeek-R1 and DeepSeek-V3 models. Leveraging an efficient Mixture...

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...